dc.contributor.author | 执行委员会, 115 | |
dc.coverage.spatial | 日内瓦 | en |
dc.date.accessioned | 2012-04-20T01:59:28Z | |
dc.date.available | 2012-04-20T01:59:28Z | |
dc.date.issued | 2005 | |
dc.identifier.govdoc | EB115/32 | |
dc.identifier.uri | https://iris.who.int/handle/10665/25352 | |
dc.description | 执行委员会第一一五届会议,临时议程项目4.9 | en |
dc.language.iso | zh | en |
dc.publisher | 世界卫生组织 | en |
dc.relation.uri | https://iris.who.int/handle/10665/25352 | |
dc.subject | Antiretroviral therapy | en |
dc.subject | Pharmaceutical products | en |
dc.subject.mesh | Anti-Retroviral Agents | en |
dc.subject.mesh | Drugs, Generic | en |
dc.subject.mesh | Pharmaceutical Preparations | en |
dc.subject.mesh | Drug Industry | en |
dc.subject.mesh | Commerce | en |
dc.subject.mesh | Developing Countries | en |
dc.title | 抗逆转录病毒药物与发展中国家:秘书处的报告 | en |
dc.type | Governing body documents | en |
dc.subject.meshqualifier | economics | en |
dc.subject.meshqualifier | legislation and jurisprudence | en |
dc.subject.meshqualifier | standards | en |
dc.subject.meshqualifier | supply and distribution | en |
dc.subject.meshqualifier | trends | en |
who.relation.languageVersion | 10665/20227 | en |
who.relation.languageVersion | 10665/22366 | en |
who.relation.languageVersion | 10665/68824 | en |
who.relation.languageVersion | 10665/22279 | en |
who.relation.languageVersion | 10665/21649 | en |
who.relation.languageVersion | 10665/20757 | en |